Insider Buying: Oscar Health, Inc. (NYSE:OSCR) Vice Chairman Purchases 358,619 Shares of Stock

by · The Cerbat Gem

Oscar Health, Inc. (NYSE:OSCR – Get Free Report) Vice Chairman Joshua Kushner purchased 358,619 shares of the company’s stock in a transaction on Wednesday, November 13th. The shares were purchased at an average cost of $13.74 per share, with a total value of $4,927,425.06. Following the transaction, the insider now directly owns 5,810,700 shares in the company, valued at $79,839,018. This trade represents a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink.

Joshua Kushner also recently made the following trade(s):

  • On Monday, November 11th, Joshua Kushner acquired 276,040 shares of Oscar Health stock. The stock was purchased at an average price of $13.58 per share, for a total transaction of $3,748,623.20.

Oscar Health Stock Performance

Shares of NYSE:OSCR traded down $0.08 during trading on Wednesday, hitting $13.48. The stock had a trading volume of 4,692,074 shares, compared to its average volume of 3,336,917. The company has a quick ratio of 0.91, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. The firm’s fifty day moving average is $18.36 and its 200 day moving average is $18.33. Oscar Health, Inc. has a 12 month low of $6.93 and a 12 month high of $23.79.

Oscar Health (NYSE:OSCR – Get Free Report) last issued its quarterly earnings results on Thursday, November 7th. The company reported ($0.22) earnings per share for the quarter, missing the consensus estimate of ($0.20) by ($0.02). The firm had revenue of $2.42 billion during the quarter, compared to analysts’ expectations of $2.33 billion. Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. Oscar Health’s revenue for the quarter was up 68.3% on a year-over-year basis. During the same period in the previous year, the company earned ($0.29) earnings per share. As a group, sell-side analysts predict that Oscar Health, Inc. will post -0.01 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of OSCR. Wealth Enhancement Advisory Services LLC lifted its stake in shares of Oscar Health by 7.5% in the third quarter. Wealth Enhancement Advisory Services LLC now owns 12,028 shares of the company’s stock worth $255,000 after buying an additional 844 shares in the last quarter. American International Group Inc. raised its position in Oscar Health by 1.3% in the 1st quarter. American International Group Inc. now owns 79,411 shares of the company’s stock worth $1,181,000 after buying an additional 1,009 shares during the last quarter. Summit Trail Advisors LLC lifted its stake in Oscar Health by 5.4% during the 2nd quarter. Summit Trail Advisors LLC now owns 20,820 shares of the company’s stock valued at $329,000 after acquiring an additional 1,065 shares during the period. KBC Group NV boosted its holdings in shares of Oscar Health by 41.2% during the 3rd quarter. KBC Group NV now owns 4,552 shares of the company’s stock valued at $97,000 after acquiring an additional 1,328 shares during the last quarter. Finally, Arizona State Retirement System boosted its holdings in shares of Oscar Health by 3.7% during the 2nd quarter. Arizona State Retirement System now owns 38,059 shares of the company’s stock valued at $602,000 after acquiring an additional 1,351 shares during the last quarter. 75.70% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on OSCR shares. Bank of America cut Oscar Health from a “neutral” rating to an “underperform” rating and cut their target price for the stock from $21.00 to $13.50 in a research note on Wednesday, November 6th. Piper Sandler reiterated an “overweight” rating and issued a $28.00 price objective on shares of Oscar Health in a report on Tuesday, September 10th. Finally, UBS Group began coverage on Oscar Health in a research note on Monday, October 7th. They set a “neutral” rating and a $23.00 target price on the stock. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $22.93.

Get Our Latest Stock Report on OSCR

Oscar Health Company Profile

(Get Free Report)

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

Further Reading